| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 194,939 | 163,977 | 113,206 | 112,888 | | Cost of Revenue | 149,288 | 129,009 | 104,387 | 106,664 | | | Gross Profit | 45,651 | 34,968 | 8,819 | 6,224 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,307 | 14,532 | 12,846 | 15,781 | | Non Recurring |
-
|
-
| 45,263 | 137,299 | | Others | 8,074 | 8,007 | 7,929 | 8,705 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,270 | 12,429 | (57,219) | (155,561) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 80 | 28 | 177 | 122 | | Earnings Before Interest And Taxes | 20,350 | 12,457 | (57,042) | (155,439) | | Interest Expense | 93 | 129 | 109 | 122 | | Income Before Tax | 20,257 | 12,328 | (57,151) | (155,561) | | Income Tax Expense | 4,926 | 4,191 | (17,005) | (35,148) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,331 | 8,137 | (40,146) | (120,413) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,331 | 8,137 | (40,146) | (120,413) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,331 | $8,137 | ($40,146) | ($120,413) |
|
0.51% Nasdaq 
0.10 (0.58%) 
Income Statement
